C

Calder Biosciences, Inc.

7 employees

Creating next-generation vaccines to protect against infection

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Antigens

Pathogens

Pre-Clinical

Universal Influenza

Clinical

Vaccine

Maternal Vaccines

immunogens

Vaccines for Old Adults

Protein Science

Virus

SARS-CoV2

Health Care

DS-Cav1

HIV

Subunit Protein

EBV

Respiratory Diseases

RSV Vaccine

BioPharma

Biopharma

Date founded

2018

Funding rounds raised

Total raised

$600K

from 4 investors over 4 rounds

C

Calder Biosciences, Inc. raised undisclosed on April 6, 2023

Investors: IndieBio and SOSV - The Accelerator VC

C

Calder Biosciences, Inc. raised $600K on July 5, 2018

Investors: National Institute of Allergy and Infectious Diseases (NIAID)

C

Calder Biosciences, Inc. raised $99K on July 2, 2016